Reps. Gallagher, Eshoo, Guthrie: Lead bipartisan group urging FDA to rapidly approve new ALS treatments
WASHINGTON, D.C. – Reps. Mike Gallagher (R-WI), Anna G. Eshoo (D-CA), Brett Guthrie (R-KY), Jan Schakowsky (D-IL), Gus Bilirakis (R-FL), Mike Quigley (D-IL),